Skip to Store Area:

CAP TODAY Product Guides

HemoCue, Glucose 201 Analyzer (Bedside Glucose 2013)

HemoCue, Glucose 201 Analyzer (Bedside Glucose 2013)

Email a Colleague

Contact Information


HemoCue

Azim Saifee
Azim.K.Saifee@hemocue.com
11331 Valley View Street
Cypress, CA 90630
800-323-1674


Name of instrument/First year sold Glucose 201 Analyzer/2002
Professional or home use professional
Total units sold in U.S./Total units sold outside U.S.
No. of contracts for product signed in 2012
Dimensions (H × W × D)/Weight 6.3 × 3.4 × 1.7 in/0.77 lbs
Analytical method or technology or enzyme system used absorbance photometry, glucose dehydrogenase
No. of disposable reagent system units per basic package 25 in vial/box; four vials/boxes per package
Disposable units shelf life/Reagent unit storage requirements 9 months from manufacture date/refrigeration
Digital readout character size/Keypad input capability 0.5 in/none
How results are displayed plasma equivalent values
Specimen types/Sampling techniques whole blood, venous, capillary, or arterial/exact amount of blood is drawn into the cuvette by capillary force
Minimum specimen volume required 5 µL
Suitable for samples from well neonates/Sick neonates yes/yes
Time from sample introduction to result availability 40–240 seconds
Batteries used/No. used/Average life of one set of batteries AA/4/150 hours
Average expected life of device/Mean time between failures 7 years/>5 years
Device warranty/Service options/Loaners provided 2 years at no extra cost/—/yes
User list or user group no
Toll-free No. for customer questions/Hours of operation 800-323-1674, 6 am–5 pm PST
Training & certification program/No. of training days provided yes/as needed
Average time for lab to complete maintenance daily: ≤5 minutes
Internal QC recommended or required as specified by accreditation
Between instrument CV (based on PT) at the following glucose levels:
• <50 mg/dL not available
• 100–200 mg/dL 3.8
• >400 mg/dL ≥272 mg/dL=2.9
• Program name, year/Challenge No./Level of mean glucose challenge sample Equalis (Swedish PT program), 2003/2003-03; 2003-07/272 mg/dL; 120 mg/dL
Accuracy/Compared to what reference method or device ±10% or ±6 mg/dL; corr=0.994/wet chemical glucose dehydrogenase, ID-GCMS
Precision/Compared to what reference method or device within run CV 1.9 percent (108 mg/dL)/—
Linear range 0–444 mg/dL
Suggested dynamic or measurement range 0–444 mg/dL
Contraindications no
Known interferences/High-altitude interference grossly lipemic samples, methemoglobin, glucosamine/no
Restrictions based on hematocrit no
Electronic and optical function checks internal electronic self-test automatically checks that the instrument’s optronic unit is working properly
Sample quantity checks visual inspection
When auto lock or shutdown occurs
User defines QC lockout intervals/QC lockout can be circumvented no/no
Information for which device supports bar-code scanning no bar-code scanner
Method of analyst identification/Identification required
Internal memory size/Maximum No. of patient results stored
Meter connections for information transfer
How meters are connected to external system to upload results
Information contained in transmission to external system
Hardware/Software for data management system
No. of different management reports system can produce
Contents downloaded from DMS to meter
LISs/HISs to which system is connected (live installs) using:
• Screen animation/Screen scraping
• Standard HL7 interface
• Proprietary protocol interface
Use 3rd-party interfacing tool or engine for LIS or HIS interfaces
LOINC can be used to identify tests when communicating with LIS
Distinguishing features (supplied by company) CLIA-waived; indicated for diagnosis of diabetes mellitus; not hematocrit-dependent; lab verification of patient home meter; no interference from maltose or galactose; no need to recalibrate
Note: a dash in lieu of an answer means company did not answer question or question is not applicable
Tabulation does not represent an endorsement by the College of American Pathologists.